European Heart Journal

Article	Citations
Corrigendum to: Backup natural pacemaker found in the heart	2531
Residual leaks after transcatheter left atrial appendage closure: why and how to assess it?	2430
Intricacies of aortic risk assessment studies: not a simple matter	1853
Pulmonary haemodynamics and pulmonary congestion: where are we now?	1751
The Antwerp score: is this the ‘new hope on the horizon’?	1416
Female representation on editorial boards of the National Societies of Cardiology Journals of the European Society of Cardiology	1261
A rare case of a dorsal mass caused by descending thoracic aortic dissection	986
New Guidelines and a focus on ischaemic heart disease, atrial fibrillation, innovative treatments of channelopathies	965
Corrigendum to: Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled	917
Meet the European Society of Cardiology Gold Medallists 2022	845
Strengthening cardiovascular trials across Australia and New Zealand—the Alliance for Cardiovascular Trials (ANZACT) Network	789
Unmeasured confounding is always unnerving: cannabis and cardiovascular risk	764
Additional value of 18fluorodeoxyglucose positron emission tomography/computed tomography combined with intracardiac echocardiography to detect lead vegetations	749
Obituary Joep Perk	712
Taking inspiration from birds to improve flow in prosthetic heart valves: an European Research Council granted project	707
The extended role of 24 h ambulatory blood pressure monitoring for reflex syncope	585
Risk of knowing too much: the tricky case of estimated glomerular filtration rate and treatment decisions in heart failure	487
Reconsidering safety and reducing barriers to MRI in patients with cardiac implantable electronic devices	464
A case of crowded heart: closing the door after the visitors	423
Isolated early peak cardiac troponin for clinical decision-making after elective cardiac surgery: useless at best	416
Doubly committed ventricular septal defect closure using an eccentric occluder via minimal incision in the anterior median sternum through the left parasternal third intercostal space	361
Elevated serum xylitol levels and cardiovascular risk: an active component or an innocent bystander?	342
Weekly journal scan: a hard RAFTing to improve long-term survival in heart failure with severely reduced ejection fraction	317
Dissecting the effect of genetic variants on atherosclerosis: integrating bulk and single-cell transcriptomics	317
Correction to: The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies	296

Early vascular disease of Olympian Paavo Nurmi despite a healthy lifestyle	254
Bulgarian Society of Cardiology: 50 years on	247
Weekly Journal Scan: no CLEAR evidence of cardiovascular benefits of colchicine after acute myocardial infarction	231
Arterial conduits for coronary bypass grafting: the set-point concept	224
Correction to: Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score	222
Weekly Journal Scan: The promise of small interfering RNA in reducing lipoprotein(a)	210
Do we need new thresholds for surgical repair in patients with ascending thoracic aortic aneurysm disease?	207
One-shot thrombolysis for the management of acute ischaemic stroke	205
Acromegaly and cardiovascular outcomes: a cohort study	200
Colchicine to prevent sympathetic denervation after acute myocardial infarction: the COLD-MI trial	193
Promising perspectives on pregnancy in women with congenital heart disease	185
Can we measurably improve the prediction of recurrent coronary artery disease events?	179
Suspected heart failure: a clinical pattern that calls for action	166
Why Y? The Y chromosome may serve a cardiovascular purpose after all	163
Hypernatremia and subclinical chronic kidney disease	162
The Year in Cardiovascular Medicine 2024: the top 10 papers in interventional cardiology	159
Mischief in the marrow: a root of cardiovascular evil	159
Brugada syndrome: can polygenic risk scores help the clinician?	159
Beyond reproductive health: the cardiovascular risks of endometriosis	156
Moderate mixed aortic valve disease -evaluation, treatment and prognosis of patients referred to heart valve center	154
High resting coronary flow velocity predicts worse survival in chronic coronary syndromes	154
Effect of tafamidis on left atrial function in patients with transthyretin amyloid cardiomyopathy	154
Characteristics and long-term ablation outcomes of supraventricular arrhythmias in hypertrophic cardiomyopathy: a 10-year, single-center experience	151
Screening for subclinical atherosclerosis in patients clinically diagnosed with familial hypercholesterolemia and determination of imaging-guided patient management strategy	151
Abnormal left-sided blood volume, wall shear stress & energy loss in patients with repaired Tetralogy of Fallot identified by 4D flow MRI	147
Effectiveness of empagliflozin in patients with heart failure and COPD: Results from EMPEROR-Preserved and EMPEROR-Reduced	147
Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up	147
Use of emgliflozine in cardiotoxicity treatment. EMPACARD-treatment registry. Six-months follow-up	145
AD-9308 ameliorates the impacts of 4-HNE on the progress of pulmonary arterial hypertension in aldehyde dehydrogenase 2*1*2 knock-in mice	145
Elevated markers of liver function are associated with poorer outcomes in HFREF: an analysis of DAPA-HF	142
Vericiguat: a QTc interval study in patients with coronary artery disease	141
Weekly Journal Scan: Angiography-derived fractional flow reserve or intravascular ultrasound to guide stenting of non-complex coronary lesions	140
Evaluating the effect of the antiPCSK9 vaccine on systemic inflammation and oxidative stress in CFA-challenged albino mice	139
Impact of catheter ablation on functional tricuspid regurgitation in patients with atrial fibrillation	130
Allied health professional-physician collaboration to enhance guideline-directed medical therapy of heart failure: expanding therapeutic opportunities	129
Regional distribution of diffuse fibrosis in the basal and mid-ventricular AHA segments in patients with type 2 diabetes	128
Ventriculo-arterial coupling parameters by cardiac magnetic imaging are associated with outcome in patients with a systemic right ventricle	125
Impact of QRS complex fragmentation on all-cause mortality before and after cardiac resynchronization therapy	125
Disparities in the access to atrial fibrillation ablation in Denmark	124
Reporting quality of randomized controlled trials of percutaneous patent foramen ovale closure for the treatment of migraine based on the CONSORT statement	123
The role of process mining tools in STEMI networks: where should we build a new primary PCI centre?	122
Artificial intelligence as a precision tool for predicting risk of in-hospital death after aortic valve replacement	122
Telomere length across spectrum of metabolic health	121
Functinal assessment in Angina and Non-Obstructive Coronary Arteries (ANOCA) patients: from Microvascular Resistance Reserve (MRR) to different subtypes of Coronary Microvascular Dysfunction (CMD)	121
Feasibility and end-user perceptions of a novel digital care assistant and support program for people after stroke or transient ischemic attack (CAPS)	121
Coronary rotational atherectomy in patients with severe aortic stenosis	121
High-sensitivity C-reactive protein is associated with cardiac dysfunction and morbidity in a community-based cohort	121
Temporal trends in infection-related hospitalizations in patients with heart failure: a nationwide study from 1997 to 2017	120
Efficacy of intravascular lithotripsy (IVL) in coronary stenosis with severe calcification: a systematic review and meta-analysis of 38 studies	120
Refining the prognosis of patients with AF using 3D transesophageal echocardiography of the left atrial appendage	118

Association of liver dysfunction with outcomes after percutaneous coronary intervention - a systematic review and meta-analysis	117
Machine learning using cardiovascular magnetic resonance to predict cardiovascular events in patients with acute myocarditis	116
Beyond secondary prevention drugs: added benefit in survival and events of a healthy lifestyle in patients after an acute coronary syndrome	114
Aortic stenosis in homozygous familial hypercholesterolaemia: a paradigm shift over a century	113
Increased right amygdala activity during the hyper-acute phase of takotsubo syndrome	112
Dementia in individuals with severe hypercholesterolemia: Korean nationwide cohort study	112
Location and impact of the infarct-related artery in acute coronary syndrome: insight from the Swiss SPUM- ACS cohort	110
Immortal Time Bias: the hidden confounder in assessing cardiosurgical treatment effects	109
Impact of co-morbidities on survival after heart transplant in females of childbearing age: analysis of the International Society for Heart and Lung Transplantation (ISHLT) Registry	108
Evaluating off-target drug effects seen in RCTs using proteomics and mendelian randomisation	107
Blood biomarkers in left-sided valvular heart disease	107
Improving early mortality risk detection in light-chain cardiac amyloidosis patients with routine echocardiographic indicators and mayo staging	106
What is there to EAARN with a CRT implantation? Predictive factors of mortality or clinical deterioration in patients receiving cardiac resynchronization therapy based on pre-implant factors	106
Extraction of leadless and tranvenous pacemakers: occurrence, causes and complications from a national US database	105
Factors for incorrect automated atrial fibrillation identification in large-scale screening	105
Dietary sodium intake and outcomes: a secondary analysis from SODIUM - HF	104
Does the quality index of adherence to the evidence-based guidelines predict mortality in patients with myocardial infarction?	102
Duration of sinus rhythm after direct current cardioversion does not predict recurrence of atrial fibrillation after subsequent catheter ablation: a multicentre study	101
Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure	100
iRight4Me: individualisation of P2Y12 inihibitors in the realworld practice - an interim report	100
Preserved left ventricular ejection fraction with abnormal myocardial work in sepsis	99
Atrial fibrillation organisation correlates with ventricular response regularity in patients with persistent atrial fibrillation	99
Quantitative assessment of myocardial fibrosis by digital image analysis: an adjunctive tool for pathologist ground truth	98
Impact of aortic valve calcium score on conductive disturbances after transcatheter aortic valve implantation: a monocentre retrospective study	98
Optimal CW-Doppler derived parameter for the diagnosis of iatrogenic mitral stenosis during transcatheter edge-to-edge repair for mitral regurgitation	98
Impact of the thin-walled sheath on the distal radial artery occlusion: a randomized trial	95
Incidentally induced atrial fibrillation during programmed electrical stimulation in patients with depressed left ventricular systolic function after an acute myocardial infarction: a CARISMA substudy	94
Comparative study of the effects of left ventricular and biventricular pacing on indices of cardiac function and clinical status of heart failure patients: preliminary results of READAPT study	92
The role of seasonal influenza immunisation in cardiovascular care: a survey of cardiologists	92
Prognostic role of data transmitted by implanted cardiac electric devices in patients with advanced heart failure referred for heart transplantation	92
Ultra-processed food consumption and risk of cardiovascular mortality in Australia: preliminary results from prospective observational study	91
Acute deterioration in dyssynchrony and systolic function from Lot-CRT to LBBB pacing	90
Comparison of fully angiography-derived versus a hybrid of angiography and pressure-wire-derived approach to assess coronary microvascular resistance: the OxAMI-Hybrid study	90
Dynamic changes of excessive trabeculation in dilated cardiomyopathy: a longitudinal cardiovascular magnetic resonance study	90
Multi-biomarker approach for predicting cardiac magnetic resonance parameters at 30 days after ST-segment elevation myocardial infarction	89
The added value of advanced echocardiography in dilated cardiomyopathy: looking at the right heart	89
Trimethylamine N-oxide as a Novel Biomarker for Left Ventricular Diastolic Dysfunction and Functional Remodeling in ST-Elevation Myocardial Infarction Patients	86
Prognosis of diastolic dysfunction in patients with preserved LVEF. Value of left atrial strain	86
Cumulative accelerometer-based sedentary time from childhood through young adulthood with progressive left ventricular remodelling in British youth: a 13-year longitudinal study	86
Identification of potential therapeutic targets for coronary artery disease based on protein array and Mendelian Randomization analysis	85
Prediction of all-cause mortality in cardiovascular patients by using machine learning models	85
Less dementia in patients with newly diagnosed atrial fibrillation adhering with a clustering of healthy lifestyle behaviours: a nationwide population-based cohort study	85
Coronary lesions suggestive of kawasaki disease in young patients presenting with acute myocardial infarction	84
Predictors of 1-year follow-up period MACE in patients with NSTEMI	84
Clinical characteristics and natural history of pre-adolescent non-syndromic hypertrophic cardiomyopathy	84
Therapeutic components of an automated digital counselling intervention for chronic heart failure	83
Association between plasma desmosine, a marker of elastin degradation, and total atherosclerotic burden measured by whole body magnetic resonance angiography	83
Correlation of Seattle Angina Questionnaire score and post-procedural outcomes in patients undergoing multi-vessel coronary intervention	83
Use of sirolimus-coated balloon in de novo small vessel coronary lesions; Long-term follow-up from a single centre registry	82
A variant noncoding region regulates Prrx1 and predisposes to atrial arrhythmias	82
Ischemic stroke in patients with congenital heart disease and atrial fibrillation	82
Gender bias in ACS management	82
The bimodal rise and fall acute coronary syndromes curves paralleling COVID-19 outbreaks	81
Real-world data from the use of ranolazine in patients with stable angina pectoris: the RANGER study	81
The specificity of cardiac troponin elevations for myocardial infarction declines with age	80
Mortality and predictors of death in women and men with congestive heart failure of different types of cardiomyopathies	80
Concomitant real-time measurement and correlation of contact force to baseline local impedance and local impedance drops in RF ablation of left and right atrial procedures	80
Phenotyping of heart failure with preserved ejection faction using health electronic records and echocardiography	80
Long-term follow-up of early leaflet thrombosis after transcatheter aortic valve replacement	79
The novel P-Wave Area index predicts low voltage areas in patients undergoing pulmonary vein isolation for treatment of atrial fibrillation	79
Do health care physician need to risk their own lives? Time to change our own attitude towards recommended physical activity	79
Prognostic impact of the serial change of a systemic inflammation-nutrition index in patients with heart failure with preserved ejection fraction: insights from pursuit-hfpef registry	78
Eisenmenger syndrome: is it the same entity in adulthood and pediatric age?	78
Follow-up on new marker confirming the optimal status in the treatment of heart failure with reduced ejection fraction	77
How to predict myocardial injury in patients with large ischaemic burden identified during stress echocardiography?	77
Post-systolic shortening index by echocardiography evaluation of dyssynchrony in the non-dilated and hypertrophied left ventricle	76
Characterisation of metabolic phenotype in aortic stenosis: insights from a multi-parametric cardiac magnetic resonance study	76
NOAC in adult congenital heart disease patients: a single-center experience	76
Impact of a 12-week supervised exercise program on weight loss trajectory, daily physical activity levels and sedentary behaviors after bariatric surgery	76
Right ventricular free wall longitudinal strain (RVFWSL) a new outcome predictor in patients candiate for TAVI	75
Combined cardiopulmonary test and exercise Doppler echocardiography in systemic sclerosis	75
Heart failure with reduced ejection fraction: predicting exercise intolerance with echocardiography	75
Long-term effects of coronavirus disease 2019 on the cardiovascular system: the CV COVID-19 registry	74
Prediction of early left ventricular recovery and adverse remodelling in patients with acute myocardial infarction: the role of non-invasive myocardial work evaluation	74
Dynamic optimization of CRT pacing using a novel algorithm improves survival in a real-world cohort of patients	74
Microvascular dysfunction and absolute coronary blood flow after percutaneous coronary intervention of a chronic total occlusion	73
His bundle pacing: safety, performance, and clinical outcomes in a single centre experience	72
Staging cardiac damage in aortic valve disease: one size fits all?	72
Rhythm versus rate control in patients with newly diagnosed atrial fibrillation: observations from the GARFIELD-AF registry	72
Myocardial performance is impaired in cardiac amyloidosis: role of myocardial work-derived parameter in differential diagnosis with phenocopies and prognostic implications	72

Comparison of mortality prediction scores in elderly patients with ICD for heart failure with reduced ejection fraction	71
Association of Body mass index and clinical outcomes in patient with coronary artery disease undergoing percutaneous coronary intervention	71
Human pericardial fluid exosomes regulate macrophage immunophenotype: new prospective for cardiovascular myocardium-epicardium crosstalk in coronary artery disease	70
Validation of HAS-BELD scoring system and risk factors of bleeding with warfarin among non-valvular atrial fibrillation patients	70
New definition of hypotension in patients with reflex syncope using 24-hour ambulatory blood pressure monitoring (SynABPM Study)	69
Age differences in the association between arterial velocity pulse index and muscle sympathetic nerve activity in hypertensive patients	69
Management of hospital resources for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) - an approach to deescalate ?	68
Spontaneous, independent, single-center renal denervation registry of a resistant hypertension multidisciplinary team	68
Long-term outcomes in patients with left bundle branch block after transcatheter aortic valve replacement	68
Deep learning for fully automated echocardiographic measurements of left ventricular wall thickness and chamber dimensions in the parasternal long-axis view	68
Estrogen-induced phenotype in hiPSC-derived cardiomyocytes of a woman affected by both Long QT Syndrome Type 2 and Polycystic Ovary Syndrome	67
Outcomes of patients with high bleeding risks characteristics presenting with acute coronary syndrome undergoing percutaneous coronary intervention	67
Atherogenic lipoprotein profile associated with anthropometric indices of obesity and their association with cardiometabolic risk markers: a cross-sectional study in community	67
Initial combination therapy for hypertension in patients of African ancestry: a systematic review and meta-analysis	67
The expression of selected microRNAs enables identification of patients with functional atrial tricuspid regurgitation. New insights into TR pathophysiology	67
Figuring out complete left ventricular reverse remodeling in tachycardiomyopathy	67
Epicardial adipose tissue volume and density is associated with cardiac dysfunction in asymptomatic people with type 2 diabetes	67
Early diastolic strain rate and its associations with estimated glomerular filtration rate and albuminuria	67
Genome-wide association study of atrial fibrillation in 114,539 Finnish individuals reveals novel locus associated with cardiac remodelling	67
The role of bystander-initiated basic life support in exercise-related sudden cardiac arrest: a systematic review	66
Routine use of 3-dimensional zoom modality with 2-dimensional transesophageal echocardiography to decide the candidacy for transcatheter device closure of atrial septal defect	66
Health-related quality of life in patients with recurrent pericarditis: results from RHAPSODY, a phase 3 study of rilonacept	66
Reduction of triglyceride-rich lipoproteins with retatrutide in type 2 diabetes may be explained by concurrent reduction in ANGPTL3/8 levels	65
An association of low-density lipoproteins and fibrinolysis in patients with severe aortic stenosis- valvular expression of fibrinolytic proteins	65
Sympathetic nerve activity changes following acute exposures to electronic and tobacco cigarette smoking in humans	65
Computed tomography plaque analysis identifies residual inflammation in recent acute myocardial infarction patients	65
Cumulative prognostic effect of diabetes and myocardial injury in patients attended in the emergency room	65
Pericardiocentesis over 3 years at a tertiary referral Australian hospital	64
Bipolar ablation of refractory ventricular arrhythmias using a novel dedicated adapter. A multicenter study	63
Uncontrolled diabetes predicts anxiety and depression in CAD patients	63
Blood pressure response during treadmill exercise testing and the risk for future cardiovascular events and new-onset hypertension	63
Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists and cancer mortality. A real-world registry	62
SARS-CoV2 infection: functional and morphological cardiopulmonary changes in elite handball players	62
Further prognostic stratification in patients with oscillatory ventilation with exercise: is there more to it than just ups and downs?	61
Influence of lead extraction on tricuspid valve function	61
Pregnancy in women with hypertrophic cardiomyopathy: observational data from the tertiary referral center registry	60
Primary care screening and prevention of heart failure coordinated by cardiologist in rural areas	60
Protective effects of different types of bariatric surgeries on myocardial ischemia-reperfusion injury in non-obese non-diabetic rats	60
Ablation therapies for paroxysmal atrial fibrillation: a systematic review and patient-level network meta-analysis	60
Targeting Neurofibromin 2 (NF2) prevents endothelial dysfunction in obesity: a study in mice and humans	60
Does incidental calcium deposition in non-cardiac CT scans predict cardiovascular morbidity and mortality in young adults? A retrospective study	59
Pulmonary artery aneurysm in pulmonary arterial hypertension associated with congenital heart disease	59
Associations between changing patterns of ST-T waves morphologies in rest electrocardiography and cardiovascular risk in an asymptomatic low risk population: a report from Ansan-Ansung cohort study	59
The impact of hydrostatic pressure on fractional flow reserve in saphenous vein grafts	59
Investigations regarding the role of NOS1AP in the heart using a conditional overexpression mouse model	59
Anticoagulation and stroke in hospitalized patients newly diagnosed with secondary atrial fibrillation: a population-based cohort study	58
Cardiac reparative therapy with adipose graft transposition procedure (AGTP) improves electrophysiological remodeling of chronic myocardial infarction	58
Release velocity improvement with a new metronome-guided chest compression protocol: preliminary results of the RITMICO study	58
Endocardial pacing compared to epicardial left ventricle pacing and right ventricle pacing: a single center long term experience in a pediatric population	57
Concomitant initiation of combination therapy with macitentan and tadalafil in pulmonary arterial hypertension (PAH) patients with comorbidities: real-world data from OPUS and OrPHeUS	57
Hemodynamic pulmonary response to exercise according to different resting pulmonary hypertension thresholds in chronic thromboembolic pulmonary disease	57
Efficacy of controlvit as a complementary strategy in reducing hospitalizations in patients with heart failure. Randomized clinical trial	56
Influence of diabetes, heart failure, and NT-proBNP on cardiovascular outcomes in patients with atrial fibrillation – insights from a cohort study of 7,412 patients with extended follow-up	56
Early quantitative pupillary response parameters have high predictive value for 30-day mortality in patients resuscitated from out-of-hospital cardiac arrest	56
Early Intervention with Impedance-guided Heart Failure Management Improves Long-term Outcome: insights From the IMPEDANCE-HF Trial	55
Induction of RAGE-NFkB signalling axis enhances SHP-2 tyrosine phosphatase expression resulting in deviant activation of diabetic monocytes	55
Impact of COVID-19 pandemics on the incidence and mortality in Takotsubo syndrome: a report from Swedish Coronary Angiography and Angioplasty Registry	55
A novel technology for heart failure that utilizes the respiratory effort to shift fluids from the lung and alleviate cardiac workloads; feasibility study in sheep	55
Effects of intravenous lysine acetylsalicylate versus oral aspirin on platelet responsiveness in patients with ST-segment elevation myocardial infarction	55
Differential efficacy and safety of oral anticoagulation in atrial fibrillation patients with or without comorbid vascular disease: insights from the GARFIELD-AF registry	55
Retracted: Cardiovascular risk profile of a young adult population with high risk for obstructive sleep apnea screened by Stop-Bang and Epworth sleepiness scale in a primary health care unit	55
Validity and utility of the questionnaire-based FRAIL scale in elderly patients with heart failure: findings from the FRAGILE-HF	55
Validation of the HFA-ICOS risk assessment tool with real-world data from a prospective cohort of breast cancer patients in treatment with anthracyclines and trastuzumab	54
The impact of non-pharmacological therapies on cardiovascular outcomes in patients with refractory angina: a systematic review and meta-analysis of randomized controlled trials	54
The impact of mitral regurgitation grade on exercise capacity following cardiac rehabilitation program after transcatheter aortic valve implantation	54
Left atrial appendage perimeter ostium evaluation by cardiac CT utilizing 3mensio technology for watchman implantation	54
Determination of left ventricular diastolic dysfunction using machine learning methods	54
Risk stratification and prognosis in pulmonary arterial hypertension: the Singapore experience	53
Cardiovascular etiologies and risk factors of survival outcomes after resuscitation for out-of-hospital cardiac arrest: data from the KoCARC registry	53
Artificial intelligence-assisted examination of cardiac health status through electrocardiogram	53
The role of sodium-glucose cotransporter 2 (SGLT2) inhibitors in epicardial adipose tissue modulation: a meta-analysis	53
Demographic, clinical characteristics, managements strategies and in-hospital outcomes of patients enrolled in prospective nationwide SCAD registry	53
Ultrasonographic and functional evaluation of forearm circulation with occluded radial artery	53
Much ado about nothing: the impact of coronary angiography on kidney function in individuals with chronic kidney disease	53
Diagnostic accuracy of handheld single-lead electrocardiographic devices to detect atrial fibrillation: an examination using more than 30,000 rhythm traces in a randomised control trial	52
Usefulness of CineECG method in identification of P-wave morphology variants in an elderly epidemiologic cohort	52
Quantifying cardiac tissue heterogeneity using high-density grid catheter: validation in porcine model	52
A larger reduction of spatial mean QRS-T angle during cardiac resynchronisation therapy is associated with a lower risk of mortality and heart failure hospitalisation	52
Blood pressure polygenic risk scores associate with resistant hypertension in individuals with type 1 diabetes	52
Echocardiography in acute pulmonary embolism for the prediction of subsequent CTEPH	52
Is left atrial reservoir strain a superior modality to predict acute left ventricular failure in hypertensive patients	51
Calculation of intraprocedural hemodynamics with computational functional dynamic in mitral valve edge-to-edge repair	51
Various arrhythmia types and their day-by-day occurrence rates over a 14-day period using a P-wave sensitive ambulatory ECG monitored population	51
Survival penalty in patients undergoing transcatheter versus surgical aortic valve replacement: is it just a question of frailty? Insights from a large cohort with demographic matching	51
Protective effects of dapagliflozin on vascular remodeling in the carotid artery following balloon injury – potential role of angiotensin and purinergic signaling	51
Changes in the immune cell landscape in the infarcted mouse heart	51
Permanent pacemaker implantation is associated with an increased risk of heart failure hospitalization in transcatheter aortic valve implantation patients with reduced systolic function	51
Implementing dynamic atrioventricular delay optimization for cardiac resynchronization therapy: an economic analysis in the EU5 countries	51
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study	51
Novel insights into the management of German patients with very high cardiovascular risk eligible for PCSK9 inhibitor treatment: baseline characteristics from the PERI-DYS study	50
Estimation of antihypertensive effect after initiating continuous positive airway pressure treatment in Japanese patients with sleep disordered breathing	50
Behavioral economics strategies for promoting adherence to treatment in heart failure patients	50
Long term trends in natriuretic peptide testing for heart failure in UK primary care: a cohort study	49
Percutaneous coronary intervention in patients with peripheral artery disease and adverse cardiovascular adverse event and bleeding	49
Heavy weekly alcohol consumption versus binge drinking after an acute coronary syndrome and risk of major adverse cardiovascular events at one year follow up	49